BMJ Evidence-Based Medicine

Papers
(The TQCC of BMJ Evidence-Based Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis374
COVID-19 and the US response: accelerating health inequities126
Is there a smoker’s paradox in COVID-19?85
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil83
Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review58
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making48
Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis47
Patient-reported outcome measures (PROMs) as proof of treatment efficacy42
Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent41
Asthma and COVID-19: review of evidence on risks and management considerations37
Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be36
Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis33
Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports33
Misleading clinical evidence and systematic reviews on ivermectin for COVID-1931
Transparency of COVID-19 vaccine trials: decisions without data31
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study29
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression27
Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances21
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?21
Making care fit manifesto21
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review20
Sacubitril, valsartan and SARS-CoV-220
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies20
Understanding of research results, evidence summaries and their applicability—not critical appraisal—are core skills of medical curriculum20
Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis19
Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone19
COVID-19 and metabolic syndrome: could diet be the key?19
Teaching clinicians shared decision making and risk communication online: an evaluation study19
How to create PICO questions about diagnostic tests19
The limits of shared decision making18
Deaths attributed to the use of medications purchased online18
Shared decision-making as a method of care18
Building capacity: getting evidence-based practice into healthcare professional curricula17
Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance17
Alcohol-based hand sanitisers: a warning to mitigate future poisonings and deaths16
Theory and practice of Bayesian and frequentist frameworks for network meta-analysis15
Rapid reviews methods series: Guidance on literature search14
Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane14
Evidence-based medicine and machine learning: a partnership with a common purpose14
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review13
Using individual participant data to improve network meta-analysis projects13
Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews12
Intervention reporting of clinical trials published in high-impact cardiology journals: effect of the TIDieR checklist and guide12
Coroners’ concerns to prevent harms: a series of coroners’ case reports to serve patient safety and educate the public, clinicians and policy-makers12
Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform12
Diclofenac in adolescents: diagnosing and treating gastrointestinal adverse drug reactions can prevent future deaths12
Breast density notification: evidence on whether benefit outweighs harm is required to inform future screening practice11
Data-dredging bias11
'Is there racism in academic medical publishing?’10
Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment10
How to humanise the COVID-19 intensive care units10
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis9
Using claims in the media to teach essential concepts for evidence-based healthcare9
Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives9
How methodological pitfalls have created widespread misunderstanding about long COVID9
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health9
Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-199
Can shared decision making address COVID-19 vaccine hesitancy?9
Replacing PICO in non-interventional studies8
Emollients and smoking: a fire hazard that could be prevented to reduce future deaths8
Should COVID-19 vaccination be mandatory?8
Delays in publishing systematic review registrations in PROSPERO are hindering transparency and may lead to research waste8
Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile8
Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis8
Hit or miss: the new cholesterol targets8
Interventions for Menière’s disease: an umbrella systematic review8
Tramadol: repeated prescriptions and repeated warnings8
Component network meta-analysis in a nutshell8
Rapid Reviews Methods Series: Involving patient and public partners, healthcare providers and policymakers as knowledge users8
Catalogue of bias: selective outcome reporting bias8
Optimising the process for conducting scoping reviews8
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic7
Registration of health and medical research7
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology7
Items for consideration in a reporting guideline for mediation analyses: a Delphi study7
Rapid reviews methods series: Guidance on assessing the certainty of evidence7
School closures during COVID-19: an overview of systematic reviews7
Correlation between the use of statins and COVID-19: what do we know?7
0.037559032440186